Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Breast Cancer Clinical Trials in Baltimore | 548 Studies

Clinical Trials Breast CancerBaltimore

Breast Cancer Clinical Trials in Baltimore

Find 548 clinical trials for breast cancer near Baltimore, Maryland. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Baltimore

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 301-320 of 548 trials

Active not recruitingOP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerThis phase 3 clinical trial compares the safety and efficacy of palazestrant (OP-1250) to the standard-of-care options of fulvestrant or an aromatase inhibitor in women and men…NCT06016738·Tucson, Arizona and 232 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedMagnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast CancerRATIONALE: Diagnostic procedures such as magnetic resonance imaging (MRI) may improve the ability to detect cancer in the unaffected breast of women recently diagnosed with…NCT00058058·Little Rock, Arkansas and 20 others

CompletedA Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast CancerThis two-arm, randomized, open-label, multicenter study will evaluate the efficacy and safety of trastuzumab emtansine in combination with pertuzumab versus trastuzumab in…NCT01966471·Scottsdale, Arizona and 294 others

CompletedTrial of Partial Breast Irradiation With Various Concurrent Chemotherapy RegimensBreast conserving therapy, (BCT), which consists of wide local excision of the tumor followed by 6 weeks of whole breast irradiation, (WBI), is integral to the management of…NCT00681993·Baltimore, Maryland

CompletedStudy of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast CancerStudy to evaluate the safety, tolerability, antitumor activity, and pharmacology of MEDI-573 in combination with an aromatase inhibitor (AI) in adult subjects with HR+…NCT01446159·Scottsdale, Arizona and 70 others

CompletedMessaging Strategies to Reduce Breast Cancer Over-screening in Older WomenThis is an online survey experiment with data collection over 2 time points two weeks apart.NCT05821023·Baltimore, Maryland

Approved for marketingAn Expanded Access Study to Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Patients With HER2-Positive Breast Cancer During the COVID-19 PandemicThis single arm, multicenter study provides the pertuzumab and trastuzumab fixed-dose combination formulation for subcutaneous injection (PH FDC SC) administered at home by a home…NCT04395508·Beverly Hills, California and 11 others

CompletedPhase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest WallThis is a research study to evaluate the effects of ThermoDox in combination with therapeutic heating of the chest wall in the treatment of recurrent regional breast cancer.NCT00826085·San Francisco, California and 5 others

CompletedSafety/Efficacy of Q-122 in Breast Cancer Patients Taking Tamoxifen or Aromatase InhibitorThis is a Phase 2 proof-of-concept (POC) study designed to determine the effectiveness of Q-122 for the treatment of Vasomotor Symptoms (VMS) versus placebo.NCT03518138·Woodstock, Georgia and 17 others

CompletedLymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast CancerRATIONALE: Surgery to remove lymph nodes in the armpit may remove cancer cells that have spread from tumors in the breast.NCT00003855·Birmingham, Alabama and 155 others

CompletedFulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-PositiveThis randomized phase III trial studies fulvestrant and lapatinib to see how well they work compared to fulvestrant and a placebo in treating postmenopausal women with stage III…NCT00390455·Little Rock, Arkansas and 367 others

UnknownLetrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast CancerRATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using letrozole may fight breast cancer by lowering the amount of estrogen the body makes.NCT00382070·Anniston, Alabama and 805 others

TerminatedAutomated Method for Breast Cancer DetectionParticipants with suspicious breast lesions by mammography will undergo fine needle aspiration (FNA) under ultrasound guidance.NCT03863522·Baltimore, Maryland and 1 other

CompletedS0927:Omega3-Fatty Acid Supp in Treating Muscle&Bone Pain&Stiffness in Pts W/Stg I,II,III Brst Canc Rec'v Hormone ThpyRATIONALE: An omega-3 fatty acid-enriched nutritional supplement may help improve muscle and bone pain and stiffness caused by hormone therapy in patients with breast cancer.NCT01385137·Mobile, Alabama and 291 others

Active not recruitingDeterminants of Resistance to Endocrine Therapy and a Cyclin-dependent Kinases 4 and 6 (CDK4/6) Inhibitor for HR+ MBCThe goal of this research study is to determine if the investigators can predict which participants will respond to endocrine therapy and a cyclin-dependent kinases 4 and 6…NCT03439735·Baltimore, Maryland

CompletedStudy Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior TreatmentsThis was a Phase II, multicenter, open-label, three-cohort, non-comparative study of alpelisib plus endocrine therapy (either fulvestrant or letrozole) in subjects (pre- and…NCT03056755·Gilbert, Arizona and 93 others

CompletedPhase I/II Study of PDR001 in Patients With Advanced MalignanciesThe purpose of this "first-in-human" study of PDR001 was to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of PDR001…NCT02404441·Baltimore, Maryland and 40 others

CompletedINCB106385 Alone or in Combination With Immunotherapy in Advanced Solid TumorsThis is a multicenter, open-label, dose-escalation/dose-expansion Phase 1 clinical study to investigate the safety, tolerability, PK profile, pharmacodynamics, and preliminary…NCT04580485·West Hollywood, California and 26 others

Active not recruitingPertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast CancerThis research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which patients are most likely to…NCT01937117·Birmingham, Alabama and 9 others

RecruitingEvaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in…NCT05879926·Birmingham, Alabama and 1260 others

PreviousPage 16 of 28Next

Other Conditions in Baltimore

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma